By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SAGE Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
SAGE Therapeutics (SAGE) Announces Positive Top-Line Data In Exploratory Trial Of SAGE-547 In Postpartum Depression 6/9/2015 7:52:34 AM
SAGE Therapeutics (SAGE) Soars as Postpartum Depression Disappears in Four New Mothers 6/9/2015 6:22:39 AM
SAGE Therapeutics To Participate In The Goldman, Sachs & Co. 36th Annual Global Healthcare Conference 6/3/2015 12:49:54 PM
SAGE Therapeutics Announces SAGE-547 Progress And First Quarter 2015 Financial Results 5/14/2015 1:24:32 PM
SAGE Therapeutics Elated as Brain Seizure Drug Shows 77% Response Rate 5/14/2015 6:01:37 AM
SAGE Therapeutics To Present At UBS Global Healthcare Conference 5/12/2015 10:25:37 AM
SAGE Therapeutics To Report First Quarter 2015 Financial Results On Thursday, May 14 5/8/2015 7:35:29 AM
Ligand Pharmaceuticals Inc. (LGND) Earns Milestone From SAGE Therapeutics For SAGE-547 4/22/2015 11:24:20 AM
SAGE Therapeutics Announces Closing Of $138 Million Public Offering Of Common Stock Including Full Exercise Of Option To Purchase Additional Shares 4/21/2015 8:40:59 AM
SAGE Therapeutics Announces First Patient Treated Under Phase 3 Expanded Access Protocol To Evaluate SAGE-547 In Patients With Super-Refractory Status Epilepticus 4/20/2015 8:01:58 AM